IL324246A - סינתזת אוליגונוקלאוטידים באמצעות נוקלאוזידים מחזוריים-פוספוריים - Google Patents

סינתזת אוליגונוקלאוטידים באמצעות נוקלאוזידים מחזוריים-פוספוריים

Info

Publication number
IL324246A
IL324246A IL324246A IL32424625A IL324246A IL 324246 A IL324246 A IL 324246A IL 324246 A IL324246 A IL 324246A IL 32424625 A IL32424625 A IL 32424625A IL 324246 A IL324246 A IL 324246A
Authority
IL
Israel
Prior art keywords
formula
ref
hydrogen
dinucleotide
certain embodiments
Prior art date
Application number
IL324246A
Other languages
English (en)
Inventor
John Moongela Andjaba
Stephen L Buchwald
Montesinos Albert Cabre
Losada Pablo Garcia
Xiaofan Liu
Joseph R Martinelli
Scott A May
Mahesh Minnath Parsutkar
Original Assignee
Lilly Co Eli
Massachusetts Inst Technology
John Moongela Andjaba
Stephen L Buchwald
Montesinos Albert Cabre
Losada Pablo Garcia
Xiaofan Liu
Joseph R Martinelli
Scott A May
Mahesh Minnath Parsutkar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Massachusetts Inst Technology, John Moongela Andjaba, Stephen L Buchwald, Montesinos Albert Cabre, Losada Pablo Garcia, Xiaofan Liu, Joseph R Martinelli, Scott A May, Mahesh Minnath Parsutkar filed Critical Lilly Co Eli
Publication of IL324246A publication Critical patent/IL324246A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/11—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
IL324246A 2023-05-08 2025-10-27 סינתזת אוליגונוקלאוטידים באמצעות נוקלאוזידים מחזוריים-פוספוריים IL324246A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202363500726P 2023-05-08 2023-05-08
EP24382484 2024-05-03
PCT/US2024/028291 WO2024233624A1 (en) 2023-05-08 2024-05-08 Oligonucleotide synthesis using cyclic-phosphorous nucleosides

Publications (1)

Publication Number Publication Date
IL324246A true IL324246A (he) 2025-12-01

Family

ID=91274520

Family Applications (1)

Application Number Title Priority Date Filing Date
IL324246A IL324246A (he) 2023-05-08 2025-10-27 סינתזת אוליגונוקלאוטידים באמצעות נוקלאוזידים מחזוריים-פוספוריים

Country Status (8)

Country Link
EP (1) EP4709735A1 (he)
JP (1) JP2026517877A (he)
KR (1) KR20250177459A (he)
CN (1) CN121443620A (he)
AU (1) AU2024270006A1 (he)
IL (1) IL324246A (he)
TW (2) TW202539695A (he)
WO (1) WO2024233624A1 (he)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6251695A (ja) * 1985-08-29 1987-03-06 Yuki Gosei Yakuhin Kogyo Kk ホスホロアミダイト類の合成法
AU2003242672B2 (en) * 2002-06-07 2009-12-17 Universitair Medisch Centrum Utrecht New compounds for modulating the activity of exhange proteins directly activated by camp (EPACS)
US8927513B2 (en) 2009-07-07 2015-01-06 Alnylam Pharmaceuticals, Inc. 5′ phosphate mimics
US9725479B2 (en) 2010-04-22 2017-08-08 Ionis Pharmaceuticals, Inc. 5′-end derivatives
WO2014124430A1 (en) * 2013-02-11 2014-08-14 Emory University Nucleotide and nucleoside therapeutic compositions and uses related thereto
WO2018045317A1 (en) 2016-09-02 2018-03-08 Dicerna Pharmaceuticals, Inc. 4'-phosphate analogs and oligonucleotides comprising the same
US20240294565A1 (en) * 2021-05-17 2024-09-05 Ligand Pharmaceuticals Incorporated Unnatural configuration nucleotide prodrug compounds

Also Published As

Publication number Publication date
JP2026517877A (ja) 2026-06-02
TW202539695A (zh) 2025-10-16
AU2024270006A1 (en) 2025-11-13
TW202508604A (zh) 2025-03-01
CN121443620A (zh) 2026-01-30
KR20250177459A (ko) 2025-12-23
EP4709735A1 (en) 2026-03-18
WO2024233624A1 (en) 2024-11-14
TWI904659B (zh) 2025-11-11

Similar Documents

Publication Publication Date Title
JP3207915B2 (ja) オリゴヌクレオチドとオリゴヌクレオチド類似体の固相合成のための方法と化合物
US20250135036A1 (en) Compositions for editing mecp2 transcripts and methods thereof
CN113748116A (zh) 可用于寡核苷酸制备的技术
KR100211552B1 (ko) 유전자 발현 억제용 화합물 및 방법
KR20220076508A (ko) 올리고뉴클레오티드 조성물 및 이의 사용 방법
KR102531388B1 (ko) 알콕시 페닐 유도체, 뉴클레오시드 보호체 및 뉴클레오티드 보호체, 올리고뉴클레오티드 제조 방법, 및 치환기 제거 방법
AU2017368283B2 (en) Novel bicyclic nucleosides and oligomers prepared therefrom
CA3253279A1 (en) OLIGONUCLEOTIDE COMPOSITIONS AND ASSOCIATED PROCESSES
KR19990022711A (ko) 올리고누클레오티드 합성을 위한 개선된 방법
US20100273999A1 (en) Preparation of Nucleotide Oligomer
JP2016164141A (ja) Rna及びその誘導体合成のための新規保護基
CA2878945A1 (en) Chiral control
JP4473445B2 (ja) リボヌクレオシド−誘導体およびその製造方法
KR20010022840A (ko) 올리고누클레오티드의 용액 상 합성
WO2005005450A1 (ja) 環状ビスジヌクレオシドの合成方法
WO2024006953A2 (en) Monomers and methods for synthesis of modified oligonucleotides
CZ19094A3 (en) Modified oligodeoxyribonucleotides, process of their preparation and pharmaceutical preparations in which they are comprised
KR20250177459A (ko) 시클릭-인 뉴클레오시드를 사용한 올리고뉴클레오티드 합성
WO2021080021A1 (ja) オリゴヌクレオチドを製造する方法
Tsurusaki et al. Development of a new synthetic method for oligodeoxynucleotides using 3′-H-phosphonamidate derivatives
WO2026030418A2 (en) Oligonucleotide synthesis using cyclic-phosphorous nucleosides
EP4667479A1 (en) Polyphosphorylated nucleoside, phosphate-activated nucleotide used for synthesis of polyphosphorylated nucleoside and method for synthesis of same, and method for synthesis of polyphosphorylated nucleoside using phosphate-activated nucleotide
JP2025517196A (ja) 合成骨格を有するオリゴヌクレオチド及びその合成
WO2025160574A1 (en) Oligonucleotide compositions and methods thereof
CN118139629A (zh) 用于编辑mecp2转录物的组合物及其方法